Literature DB >> 20520657

Enhanced interrogation: emerging strategies for cell signaling inhibition.

Rong Huang1, Isabel Martinez-Ferrando, Philip A Cole.   

Abstract

Here we summarize recent and developing chemical approaches for modulating signaling pathways. In particular, we discuss targeting mutant signaling proteins, disrupting protein-protein interactions in cellular signaling networks, designing bivalent inhibitors of signaling proteins and identifying allosteric regulators of signaling enzymes. Over the past decade, great progress in the harvesting of chemical tools for basic research and clinical medicine has been made, but many challenges remain, and examples of exciting future targets are highlighted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20520657      PMCID: PMC3160762          DOI: 10.1038/nsmb0610-646

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  46 in total

1.  Pharmacological rescue of mutant p53 conformation and function.

Authors:  B A Foster; H A Coffey; M J Morin; F Rastinejad
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

Review 2.  Protein kinase inhibition of clinically important staurosporine analogues.

Authors:  Osman A B S M Gani; Richard A Engh
Journal:  Nat Prod Rep       Date:  2010-03-04       Impact factor: 13.423

Review 3.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).

Authors:  Marie-Pierre de Béthune
Journal:  Antiviral Res       Date:  2009-09-23       Impact factor: 5.970

4.  Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.

Authors:  Nicolas Basse; Joel L Kaar; Giovanni Settanni; Andreas C Joerger; Trevor J Rutherford; Alan R Fersht
Journal:  Chem Biol       Date:  2010-01-29

5.  Allosteric modulation of Ras positions Q61 for a direct role in catalysis.

Authors:  Greg Buhrman; Genevieve Holzapfel; Susan Fetics; Carla Mattos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

6.  Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Authors:  M M Georgescu; K H Kirsch; P Kaloudis; H Yang; N P Pavletich; H Hanafusa
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

7.  Mechanism-based design of a protein kinase inhibitor.

Authors:  K Parang; J H Till; A J Ablooglu; R A Kohanski; S R Hubbard; P A Cole
Journal:  Nat Struct Biol       Date:  2001-01

8.  Direct inhibition of the NOTCH transcription factor complex.

Authors:  Raymond E Moellering; Melanie Cornejo; Tina N Davis; Cristina Del Bianco; Jon C Aster; Stephen C Blacklow; Andrew L Kung; D Gary Gilliland; Gregory L Verdine; James E Bradner
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

Review 9.  Emerging Raf inhibitors.

Authors:  James A McCubrey; Linda S Steelman; Steven L Abrams; William H Chappell; Suzanne Russo; Roger Ove; Michele Milella; Agostino Tafuri; Paolo Lunghi; Antonio Bonati; Franca Stivala; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; Giuseppe Montalto; Melchiorre Cervello
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

10.  Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.

Authors:  Jianming Zhang; Francisco J Adrián; Wolfgang Jahnke; Sandra W Cowan-Jacob; Allen G Li; Roxana E Iacob; Taebo Sim; John Powers; Christine Dierks; Fangxian Sun; Gui-Rong Guo; Qiang Ding; Barun Okram; Yongmun Choi; Amy Wojciechowski; Xianming Deng; Guoxun Liu; Gabriele Fendrich; André Strauss; Navratna Vajpai; Stephan Grzesiek; Tove Tuntland; Yi Liu; Badry Bursulaya; Mohammad Azam; Paul W Manley; John R Engen; George Q Daley; Markus Warmuth; Nathanael S Gray
Journal:  Nature       Date:  2010-01-13       Impact factor: 49.962

View more
  7 in total

1.  Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.

Authors:  Dongxing Chen; Cheng Dong; Guangping Dong; Karthik Srinivasan; Jinrong Min; Nicholas Noinaj; Rong Huang
Journal:  J Med Chem       Date:  2020-07-16       Impact factor: 7.446

2.  Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.

Authors:  Gang Zhang; Stacie Lynn Richardson; Yunfei Mao; Rong Huang
Journal:  Org Biomol Chem       Date:  2015-02-25       Impact factor: 3.876

3.  Exploring Unconventional SAM Analogues To Build Cell-Potent Bisubstrate Inhibitors for Nicotinamide N-Methyltransferase.

Authors:  Iredia D Iyamu; Jonah Z Vilseck; Ravi Yadav; Nicholas Noinaj; Rong Huang
Journal:  Angew Chem Int Ed Engl       Date:  2022-02-23       Impact factor: 15.336

Review 4.  SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.

Authors:  Jing Zhang; Yujun George Zheng
Journal:  ACS Chem Biol       Date:  2015-11-16       Impact factor: 5.100

5.  In Vitro Selection of Cathepsin E-Activity-Enhancing Peptide Aptamers at Neutral pH.

Authors:  Madhu Biyani; Masae Futakami; Koichiro Kitamura; Tomoyo Kawakubo; Miho Suzuki; Kenji Yamamoto; Koichi Nishigaki
Journal:  Int J Pept       Date:  2011-03-22

6.  Bound water at protein-protein interfaces: partners, roles and hydrophobic bubbles as a conserved motif.

Authors:  Mostafa H Ahmed; Francesca Spyrakis; Pietro Cozzini; Parijat K Tripathi; Andrea Mozzarelli; J Neel Scarsdale; Martin A Safo; Glen E Kellogg
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

Review 7.  The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!

Authors:  Daniel N A Tagoe; Titilola D Kalejaiye; Harry P de Koning
Journal:  Front Pharmacol       Date:  2015-09-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.